Cronos Group Inc (CRON)
$6.82
0.44 (6.06%)
CRON Stock Quote Delayed 15 Minutes
Previous Close
$6.82
Market Cap
1.20B
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
10.26M
Day's Range
6.65 - 7.07
52-Week Range
6.65 - 25.10
Dividend & Yield
N/A (N/A)
CRON Stock Predictions, Articles, and Cronos Group Inc News
Stock Market Today: Cannabis Gets Crushed
Walmart and Cisco stock beat on earnings, but fell on Thursday. Here's what happened in the stock market today.
Q3 Numbers Show Why Cronos Stock May Not Rebound in the Short Term
CRON stock will head way higher in the long run. But, the long-term rebound won't start until today's weak profit trends improve.
Beneath the Q3 Setback Is an Opportunity for CRON Stock
The third quarter earnings season isn’t getting off on the right foot for Cronos Group stock. Still, a key pivot toward the U.S. CBD market could be one of the hidden catalysts for a recovery.
Cronos Group Earnings: CRON Stock Ticks 1% Lower on Q3 Results
Cronos Group (CRON) earnings for the Canadian marijuana company's third quarter of the year have CRON stock down on Tuesday.
With Altria in the Driver’s Seat, It’s Tough to Play Cronos Stock
This makes it tough for average investors to win with Cronos stock. On the other hand, high-short interest may mean its too late to go short CRON. The company's shares could rally in a short squeeze scenario. So what's your play with Cronos stock? Avoid!
Investors Should Use Other Metrics to Evaluate Cronos Group Stock
Some believe that Cronos stock overvalued. But if you consider cash on the balance sheet, CRON stock is more than reasonable.
Cronos Stock Will Eventually Rebound, but Not Anytime Soon
Like many other high quality pot stocks, CRON stock will eventually rebound from this sell-off, but not here, and not now.
Don’t Count on Altria to Keep the Price of Cronos Stock Propped Up
Cronos stock is severely overvalued and is likely to fall further. Cronos is more expensive than any other Canadian cannabis stock, even despite the recent Altria investment
Friday’s Vital Data: Intel, Tesla and Cronos Group
Options trading was hot in Intel, Tesla and Cronos Group stocks on Thursday. Here’s what the data suggests moving forward.
Investors Should Jump Into Cronos Group Stock’s Mystery Moves
CRON stock is not for the faint of heart. Do you think you have what it takes to profit from this pot powerhouse?
Friday’s Vital Data: Cronos Group, Netflix and Disney
Options trading was buzzing in Cronos Group, Netflix and Disney on Thursday. Here are the metrics that matter moving forward.
Cronos Australia Offers Little Help to Cronos Group Stock
Cronos Australia could help lend some credibility to Cronos Group, but it appears too small to significantly affect CRON stock.
4 Reasons to Buy Cronos Stock On the Vaping Dip
CRON stock is down more than 50% on concerns about slowing cannabis growth in Canada and vaping-related health concerns. However, there are plenty of reasons for long-term investors to buy the dip.
Altria’s Juul Labs Investment Not Looking So Hot
While I believe that regulators will ultimately get this entire health scare sorted and both Juul and Cronos will go back to running their businesses, I can’t help but think how relieved Altria’s management must be that they made the $1.8 billion investment in Cronos in exchange for 45% of its stock.
Avoid Cronos Group Stock Even After Yesterday’s Cannabis Carnage
Health impact of vaping makes CRON stock a concern from a regulatory and growth perspective. Keep it on the investment radar, but shares aren't likely to trend higher anytime soon.
Stock Market Today: Trade Talks Start; Cannabis Stocks Burned
Cannabis stocks were torched Thursday, while trade talks continue. Here's what happened in the stock market today.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
B
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!
